$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
吃多吉美多久起效呢?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗肾癌效果好吗?
2025-10-19 11:44:20
Check Details
索拉非尼治疗肾癌效果怎么样呢?
2025-10-19 11:44:20
Check Details
多吉美治疗肾癌的效果如何呢?
2025-10-19 11:44:20
Check Details
肾癌靶向药仑伐替尼
2025-10-19 11:44:20
Check Details
乐伐替尼耐药后处理
2025-10-19 11:44:20
Check Details
索拉非尼治疗肾癌效果好不好?
2025-10-19 11:44:20
Check Details
索拉非尼是治什么病症的?
2025-10-19 11:44:20
Check Details
多吉美的适应症有什么呢?
2025-10-19 11:44:20
Check Details
乐伐替尼治疗期间要注意什么呢?
2025-10-19 11:44:20
Check Details
乐伐替尼最新中文版说明书
2025-10-19 11:44:20
Check Details
乐伐替尼该注意的事项有什么?
2025-10-19 11:44:20
Check Details
1
2
...
8230
8231
8232
8233
8234
8235
8236
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pixclara (Floretyrosine F-18/18F-FET) Glioma PET: Distinguishing Recurrence from Treatment-Related Change
2
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
3
Bexlutry (Lu-177 Dotatate) for SSTR-Positive GEP-NETs: PRRT Dosing and Safety Monitoring
4
Etrasimod for Ulcerative Colitis: 2mg Once Daily, Onset Timeline, and Safety Monitoring
5
Hibsago (Bepirovirsen) Japan Approval: CHB Functional Cure and B-Well Data Essentials
6
FDA Approves Isembyld (apitegromab-mstn), the World’s First Skeletal Muscle-Targeted Therapy for SMA
7
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
8
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
9
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
10
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
11
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
12
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments